Sedgwick J D, Mössner R, Schwender S, ter Meulen V
Institute for Virology and Immunobiology, University of Würzburg, Germany.
J Exp Med. 1991 May 1;173(5):1235-46. doi: 10.1084/jem.173.5.1235.
The potential of cells within the central nervous system (CNS) to initiate T lymphocyte responses is not known and was the subject of this study. Using the ability of virgin T lymphocytes to proliferate in a primary response to allogeneic determinants on antigen-presenting cells (APC), we have examined the capacity of major histocompatibility complex (MHC)-expressing astroglial cells to act as stimulators of primary and secondary T cell responses. Neither freshly isolated astrocytes nor primary astrocyte cultures pretreated with interferon gamma (IFN-gamma) to upregulate MHC class I and II expression stimulated unfractionated lymph node (LN) cell populations in the primary mixed lymphocyte reaction. In mixing experiments, astrocytes did not inhibit the T cell response to allogeneic LN stimulators. Purified responder CD4+ T cells also were not stimulated to proliferate or secrete interleukin 2 (IL-2) by MHC class I- and II-expressing astrocytes. In contrast to their inability to stimulate virgin, alloreactive CD4+ T cells, astrocytes were able to specifically stimulate an alloreactive CD4+ T cell line. Unprimed CD8+ T cells, however, exhibited some weak autonomous proliferation to astrocyte stimulators but this response was only substantial in the presence of exogenous IL-2, the latter predominantly being a CD4+ T cell product. Those CD8+ T cells responding in the presence of IL-2 were mainly T cell receptor alpha/beta+ IL-2 receptor (alpha chain)+, and a majority had shifted from high to low CD45R expression. Given the virtual dependence of CD8+ T cells in these studies, on CD4+ T cell help, and the complete absence of activation of this latter subset by astrocytes, it is clear that in the context of this resident CNS cell, further activation of either T cell subset by astrocytes within the CNS can only follow priming by another type of APC. The implications of these results for the induction of T cell responses in the CNS are discussed.
中枢神经系统(CNS)内的细胞引发T淋巴细胞反应的潜力尚不清楚,这也是本研究的主题。利用原始T淋巴细胞在对抗原呈递细胞(APC)上的同种异体决定簇的初次反应中增殖的能力,我们检测了表达主要组织相容性复合体(MHC)的星形胶质细胞作为初次和二次T细胞反应刺激物的能力。无论是新鲜分离的星形胶质细胞,还是用γ干扰素(IFN-γ)预处理以上调MHC I类和II类表达后的原代星形胶质细胞培养物,在初次混合淋巴细胞反应中均未刺激未分级的淋巴结(LN)细胞群体。在混合实验中,星形胶质细胞并未抑制T细胞对同种异体LN刺激物的反应。表达MHC I类和II类的星形胶质细胞也未刺激纯化的反应性CD4+ T细胞增殖或分泌白细胞介素2(IL-2)。与它们无法刺激原始的、同种异体反应性CD4+ T细胞相反,星形胶质细胞能够特异性刺激同种异体反应性CD4+ T细胞系。然而,未致敏的CD8+ T细胞对星形胶质细胞刺激物表现出一些微弱的自主增殖,但这种反应仅在外源IL-2存在时才显著,而IL-2主要是CD4+ T细胞产物。那些在IL-2存在下做出反应的CD8+ T细胞主要是T细胞受体α/β+ IL-2受体(α链)+,并且大多数已从高CD45R表达转变为低CD45R表达。鉴于在这些研究中CD8+ T细胞实际上依赖于CD4+ T细胞的辅助,并且星形胶质细胞完全未激活后一个亚群,很明显,在这种中枢神经系统驻留细胞的背景下,中枢神经系统内的星形胶质细胞对任一T细胞亚群的进一步激活只能在另一种类型的APC引发之后发生。本文讨论了这些结果对中枢神经系统中T细胞反应诱导的意义。